Consumer Cyclical

Bath & Body Works, Inc. (BBWI)

$3.8B
Market Cap
6.0
P/E Ratio
1.42
Beta
4.28%
Dividend Yield
Piotroski 5/9Altman Z 2.3 Gray ZoneBeneish M -3.01 CleanROIC−WACC +17.4%

Quantitative Summary

Deterministic

At 6.0x earnings — a 83% discount to the sector average of 35.0x — BBWI is in the lower valuation range. Financial health is average: Piotroski 5/9, Altman Z 2.3.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency for Bath & Body Works presents a stark dichotomy between operational cash generation and equity structure. The company demonstrates robust fundamental quality with an ROIC of 26.3% significantly exceeding the WACC of 8.9%, creating a +17.4% spread that indicates strong value creation potential from core operations. This is underpinned by healthy gross margins at 43.7% and a Piotroski F-Score of 5/9, suggesting moderate financial strength with no evidence of earnings manipulation given the negative Beneish M-Score of -3.01. However, the DuPont decomposition reveals that reported ROE is severely distorted to -50.7%, driven entirely by an equity multiplier of -3.96x; this negative leverage suggests substantial debt or off-balance-sheet liabilities are inflating total capital while depressing shareholder returns on book value.

Valuation metrics further highlight a significant divergence between market pricing and intrinsic models derived from the provided data. The current P/E ratio of 6.0x stands in sharp contrast to both historical norms and the sector average of 36.4x, implying that the market has priced in severe distress or terminal decline despite the positive ROIC-WACC spread. Conversely, a DCF model suggests an implied fair value of $61, indicating that current equity pricing may be disconnected from projected cash flows if growth assumptions align with historical patterns rather than recent stagnation. The near-flat revenue trajectory of -0.2% YoY complicates this picture, as the market appears to have discounted future expansion entirely while ignoring the underlying operational efficiency metrics.

Risk assessment parameters offer limited directional clarity regarding immediate catalysts or downside protection. Insider activity over the last 90 days remains neutral with zero net flow, providing no clear signal of management confidence or distress selling. While the Altman Z-Score of 2.3 places the firm in a "grey zone" between safety and bankruptcy risk, it does not currently flag imminent insolvency. The combination of extreme valuation compression relative to peers and distorted equity metrics creates an environment where traditional fundamental analysis yields conflicting signals regarding long-term viability versus short-term opportunistic entry points based on mean reversion expectations.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6.9%8.9%10.9%
2%$80$53$38
3%$99$61$42
4%$133$73$48

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.9%, terminal growth 3%. Fair value $61 (+0.0%). Not investment advice.

Valuation Context

6.0x
BBWI P/E
35.0x
Sector Avg
-83%
vs Sector

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
2.3
Altman Z-Score
Grey Zone — between 1.8 and 3.0 thresholds. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-3.01
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

43.7%
Gross Margin
8.9%
Net Margin
26.3%
ROIC
8.9%
WACC
ROIC − WACC Spread: +17.4%— Positive value creation spread.
-0.2%
Revenue Growth (YoY)
-18.7%
Earnings Growth (YoY)
865.0M
Free Cash Flow
19%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

8.9%
Net Profit Margin
NI ÷ Revenue
×
1.44x
Asset Turnover
Revenue ÷ Assets
×
-3.96x
Equity Multiplier
Assets ÷ Equity
=
-50.7%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

-4.96x
Debt / Equity
1.27x
Current Ratio
4.2x
Interest Coverage
1.9x
Net Debt / EBITDA
13.35%
FCF Yield
1.4B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.47
Act: $0.49
+4.0%
Q3
✗ Miss
Est: $0.38
Act: $0.37
-1.9%
Q2
✗ Miss
Est: $0.40
Act: $0.35
-11.9%
Q1
✓ Beat
Est: $1.77
Act: $2.05
+15.8%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

6.5
Forward P/E
PEG Ratio
-2.93
Price/Book
5M
Avg Volume
$34.66
52W High
$14.28
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$133M
Tracked Passive Exposure
8
ETFs Holding BBWI
0.06%
Avg Weight in ETFs
$214B
Total ETF AUM

When investors buy or sell ETFs like XRT or VFVA, the fund manager is mechanically forced to buy or sell BBWI shares regardless of Bath & Body Works, Inc.'s individual fundamentals. We estimate $133M of passive capital is structurally linked to BBWI through 8 tracked ETFs. Passive flows have a limited but growing influence on BBWI's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in Bath & Body Works, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.

BBWI Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
BBWIEpicenterVYMETFVBRETFMDYETFAMZNLow RiskTSLALow RiskHDLow RiskTGTLow RiskMCDLow Risk
BBWI Price Drop (%)0

If Bath & Body Works, Inc. (BBWI) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Amazon.com Inc. (AMZN) as the most exposed collateral stock, sharing 1 ETFs with BBWI. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 10 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

BBWI Ownership Dynamics

Ticker
BBWI

Float lock-up computed from 11 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

BBWI Capital Efficiency

How efficiently does Bath & Body Works, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$865M
EBITDA
$1.4B
FCF Conversion
61%
Reinvestment Rate
39%
61% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
26.3%
ROIC − WACC Spread
17.4%

Bath & Body Works, Inc. converts 61% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 17.4% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-0521,670$18.56$402,195.2
2026-04-0824$18.09$434.16
2026-04-061,121$18.57$20,816.97
2026-03-261,227$18.19$22,319.13
2026-02-244,435$22.52$99,876.2
2026-02-172,937$24.07$70,693.59
2026-01-21187,449$21.65$4.1M
2026-01-0566,831$20.74$1.4M
2026-01-021,693$20.08$33,995.44
2025-12-2910,509$19.79$207,973.11
2025-12-24158$19.25$3,041.5
2025-12-22126,120$19.79$2.5M
2025-12-19129,170$19.62$2.5M
2025-12-18136,919$19.67$2.7M
2025-12-12438$19.94$8,733.72
2025-12-114,034$19.53$78,784.02
2025-12-0216,305$18.98$309,468.9
2025-12-0156,576$17.41$984,988.16
2025-11-13266$22.40$5,958.4
2025-11-1291$21.96$1,998.36
2025-11-1098,859$22.91$2.3M
2025-10-31920$23.93$22,015.6
2025-10-142,977$25.79$76,776.83

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare BBWI to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.